日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VDAC2 loss elicits tumour destruction and inflammation for cancer therapy

VDAC2缺失可引发肿瘤破坏和炎症,从而促进癌症治疗。

Sujing Yuan # ,Renqiang Sun # ,Hao Shi ,Nicole M Chapman ,Haoran Hu ,Cliff Guy ,Sherri Rankin ,Anil Kc ,Gustavo Palacios ,Xiaoxi Meng ,Xiang Sun ,Peipei Zhou ,Xiaoyang Yang ,Stephen Gottschalk ,Hongbo Chi

SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity

cDC1细胞中的SLC38A2和谷氨酰胺信号传导决定抗肿瘤免疫

Chuansheng Guo ,Zhiyuan You ,Hao Shi ,Yu Sun ,Xingrong Du ,Gustavo Palacios ,Cliff Guy ,Sujing Yuan ,Nicole M Chapman ,Seon Ah Lim ,Xiang Sun ,Jordy Saravia ,Sherri Rankin ,Yogesh Dhungana ,Hongbo Chi

Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer

单细胞 CRISPR 筛选在体内绘制癌症中 T 细胞命运调控组图谱

Peipei Zhou # ,Hao Shi # ,Hongling Huang # ,Xiang Sun ,Sujing Yuan ,Nicole M Chapman ,Jon P Connelly ,Seon Ah Lim ,Jordy Saravia ,Anil Kc ,Shondra M Pruett-Miller ,Hongbo Chi

Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer

单细胞 CRISPR 筛选在体内绘制癌症中 T 细胞命运调控组图谱

Peipei Zhou #,Hao Shi #,Hongling Huang #,Xiang Sun,Sujing Yuan,Nicole M Chapman,Jon P Connelly,Seon Ah Lim,Jordy Saravia,Anil Kc,Shondra M Pruett-Miller,Hongbo Chi

SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity

cDC1细胞中的SLC38A2和谷氨酰胺信号传导决定抗肿瘤免疫

Chuansheng Guo,Zhiyuan You,Hao Shi,Yu Sun,Xingrong Du,Gustavo Palacios,Cliff Guy,Sujing Yuan,Nicole M Chapman,Seon Ah Lim,Xiang Sun,Jordy Saravia,Sherri Rankin,Yogesh Dhungana,Hongbo Chi

cBAF complex components and MYC cooperate early in CD8+ T cell fate

cBAF复合物组分和MYC在CD8+ T细胞命运的早期阶段协同作用

Ao Guo # ,Hongling Huang # ,Zhexin Zhu ,Mark J Chen ,Hao Shi ,Sujing Yuan ,Piyush Sharma ,Jon P Connelly ,Swantje Liedmann ,Yogesh Dhungana ,Zhenrui Li ,Dalia Haydar ,Mao Yang ,Helen Beere ,Jason T Yustein ,Christopher DeRenzo ,Shondra M Pruett-Miller ,Jeremy Chase Crawford ,Giedre Krenciute ,Charles W M Roberts ,Hongbo Chi ,Douglas R Green

cBAF complex components and MYC cooperate early in CD8+ T cell fate

cBAF复合物组分和MYC在CD8+ T细胞命运的早期阶段协同作用

Ao Guo #,Hongling Huang #,Zhexin Zhu,Mark J Chen,Hao Shi,Sujing Yuan,Piyush Sharma,Jon P Connelly,Swantje Liedmann,Yogesh Dhungana,Zhenrui Li,Dalia Haydar,Mao Yang,Helen Beere,Jason T Yustein,Christopher DeRenzo,Shondra M Pruett-Miller,Jeremy Chase Crawford,Giedre Krenciute,Charles W M Roberts,Hongbo Chi,Douglas R Green

Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2

表观遗传药物筛选发现IOX1通过靶向TET2抑制Th17介导的炎症。

Xiao Hu ,Yanli Zou ,David A Copland ,Lauren P Schewitz-Bowers ,Yan Li ,Philippa J P Lait ,Madeleine Stimpson ,Zhihui Zhang ,Shixin Guo ,Juanran Liang ,Tingting Chen ,Jing Jing Li ,Sujing Yuan ,Shuo Li ,Penghui Zhou ,Yizhi Liu ,Andrew D Dick ,Xiaofeng Wen ,Richard W J Lee ,Lai Wei

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer

卡非佐米调节肿瘤微环境以增强癌症免疫检查点治疗

Qian Zhou, Jinxia Liang, Tong Yang, Jin Liu, Bo Li, Yingchang Li, Zhenzhen Fan, Weida Wang, Wensheng Chen, Sujing Yuan, Meng Xu, Qigui Xu, Zhidong Luan, Zhongjun Xia, Penghui Zhou, Yadong Huang, Liang Chen

RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion

携带 shPKM2 的 RGD 修饰溶瘤腺病毒通过抑制自噬和促进细胞凋亡在胰腺癌中表现出强大的细胞毒作用

Yanni Xu, Liang Chu, Sujing Yuan, Yuanqin Yang, Yu Yang, Bin Xu, Kangjian Zhang, Xin-Yuan Liu, Ruwei Wang, Ling Fang, Zhinan Chen, Zongsuo Liang